6 documents found, page 1 of 1
Open-label phase 3 study of intravenous golimumab in patients with polyarticula...
Ruperto, Nicolino; Brunner, Hermine; Pacheco-Tena, Cesar; Louw, Ingrid; Vega-Cornejo, Gabriel; Spindler, Alberto J.; Kingsbury, Daniel J.Made available in DSpace on 2022-04-28T17:22:32Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-10-01; Janssen Research & Development, LLC; Objectives. To assess efficacy, pharmacokinetics (PK) and safety of intravenous (i.v.) golimumab in patients with polyarticular-course JIA (pc-JIA). Methods. Children aged 2 to <18 years with active pc-JIA despite MTX therapy for >= 2months received 80 mg/m(2) golimu...
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Sy...
Chalhoub, Nathalie E.; Wenderfer, Scott E.; Levy, Deborah M.; Rouster-Stevens, Kelly; Aggarwal, Amita; Savani, Sonia I.; Ruth, Natasha M.Made available in DSpace on 2022-04-28T19:49:00Z (GMT). No. of bitstreams: 0 Previous issue date: 2022-02-01; Arthritis Foundation; Institute of Clinical and Translational Sciences; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq); Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabet...
Open-label phase 3 study of intravenous golimumab in patients with polyarticula...
Ruperto, Nicolino; Brunner, Hermine I; Pacheco-Tena, César; Louw, Ingrid; Vega-Cornejo, Gabriel; Spindler, Alberto J; Kingsbury, Daniel JMade available in DSpace on 2022-04-29T08:30:48Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-10-01; Objectives: To assess efficacy, pharmacokinetics (PK) and safety of intravenous (i.v.) golimumab in patients with polyarticular-course JIA (pc-JIA). Methods: Children aged 2 to <18 years with active pc-JIA despite MTX therapy for ≥2 months received 80 mg/m2 golimumab at weeks 0, 4, then every 8 weeks th...
Juvenile arthritis management in less resourced countries (JAMLess): consensus ...
Scott, Christiaan; Chan, Mercedes; Slamang, Waheba; Okong'o, Lawrence; Petty, Ross; Laxer, Ronald M.; Katsicas, Maria-Martha; Fredrick, FrancisMade available in DSpace on 2019-10-04T11:56:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-02-01; International Leagues of Associations for Rheumatology (ILAR) Grant; Juvenile idiopathic arthritis (JIA) is the most prevalent chronic rheumatic disease in children and young people (CYP) and a major cause of pain and disability. The vast majority of the world's children and their families live in less ...
Phenotypic variability and disparities in treatment and outcomes of childhood a...
Consolaro, Alessandro; Giancane, Gabriella; Alongi, Alessandra; van Dijkhuizen, Evert Hendrik Pieter; Aggarwal, Amita; Al-Mayouf, Sulaiman M.Made available in DSpace on 2019-10-05T16:54:20Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-04-01; IRCCS Istituto Giannina Gaslini; Background To our knowledge, the characteristics and burden of childhood arthritis have never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study, the prevalence of disease categories, treatment methods, and disease status in patients...
Treating juvenile idiopathic arthritis to target: Recommendations of an interna...
Ravelli, Angelo; Consolaro, Alessandro; Horneff, Gerd; Laxer, Ronald M.; Lovell, Daniel J.; Wulffraat, Nico M.; Akikusa, Jonathan D.Made available in DSpace on 2018-12-11T16:53:21Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-06-01; Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an achievable goal for most patients. Reaching this target leads to improved outcomes. The objective was to develop recommendations for treating JIA to target. A Steering Committee formulated a set of recommendations ...